Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E ε4 Is Associated With Disease-specific Effects On Brain Atrophy In Alzheimer's Disease And Frontotemporal Dementia

F. Agosta, K. Vossel, B. Miller, R. Migliaccio, S. Bonasera, M. Filippi, A. Boxer, A. Karydas, K. Possin, M. Gorno-Tempini
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Apolipoprotein ε4 (apoE4) has been strongly linked with Alzheimer's disease (AD) and contributes to several other neurological disorders. We investigated the influence of ε4 allele carrier status on the pattern of gray matter atrophy and disease severity in 51 patients with probable AD and 31 patients with behavioral variant frontotemporal dementia (bvFTD), compared with 56 healthy controls. Voxel-based morphometry was performed by using statistical parametric mapping. The ε4 allele frequency was higher in the AD group (P < 0.001) than the controls but not in the bvFTD group. No differences in demographic or cognitive profiles were observed between ε4 allele carriers and noncarriers within any of the diagnostic groups. However, ε4 carrier status was associated with more severe brain atrophy in disease-specific regions compared with noncarriers in both AD and bvFTD. AD ε4 carriers showed greater atrophy in the bilateral parietal cortex and right hippocampus, and bvFTD ε4 carriers demonstrated greater atrophy in the bilateral medial, dorsolateral, and orbital frontal cortex, anterior insula, and cingulate cortex with right predominance. This regional ε4 effect is consistent with the hypothesis that apoE may affect the morphologic expression uniquely in different neurodegenerative diseases. The atrophy patterns in ε4 carriers may indicate that they are at greater risk for clinical progression.
This paper references
10.1126/SCIENCE.3283935
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
R. Mahley (1988)
10.1006/nimg.1995.1007
Analysis of fMRI Time-Series Revisited
Karl J. Friston (1995)
10.1016/0306-4522(95)00014-A
Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes
M. Lehtovirta (1995)
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer’s disease
T Gomez-Isla (1996)
10.1001/JAMA.278.16.1349
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L. Farrer (1997)
10.1016/S0197-4580(97)00057-2
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
M. Ball (1997)
10.1097/00005072-199710000-00002
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
B. Hyman (1997)
10.1001/JAMA.1997.03550160069041
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis
L. Farrer (1997)
Consen - sus recommendations for the postmortem diagnosis of Alzheimer ’ s disease
GM McKhann (1997)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium Jama 278:1349–1356
LA Farrer (1997)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer
L A Farrer (1997)
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51:1546–1554
D Neary (1998)
10.1212/WNL.53.5.1158-b
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
R. Faber (1999)
10.1073/PNAS.050004797
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
D. Holtzman (2000)
10.1136/jnnp.68.1.93
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study
C. Geroldi (2000)
10.1001/ARCHNEUR.58.11.1803
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.
G. Mckhann (2001)
10.1212/WNL.58.2.198
Patterns of brain atrophy in frontotemporal dementia and semantic dementia
H. Rosen (2002)
10.1006/nimg.2002.1202
Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias
C. Good (2002)
10.1001/ARCHNEUR.59.10.1622
Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families.
D. Tsuang (2002)
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.
E. Mori (2002)
10.1002/ana.10093
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele
E. Mori (2002)
10.1136/jnnp.72.5.639
Apolipoprotein E polymorphism in German patients with frontotemporal degeneration
M. Riemenschneider (2002)
10.1136/jnnp.2003.012096
Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer’s disease
J. Tian (2004)
Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
C. Marra (2004)
10.1212/01.WNL.0000128089.53030.AC
Apolipoprotein E controls the risk and age at onset of Parkinson disease
Y. Li (2004)
10.1007/s10048-004-0193-0
Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis
Yi-Ju Li (2004)
10.1159/000079191
Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients
C. Marra (2004)
10.1016/j.neulet.2003.11.042
APOE and modulation of Alzheimer's and frontotemporal dementia
M. Boccardi (2004)
10.1016/j.neuroimage.2005.02.018
Unified segmentation
J. Ashburner (2005)
10.1016/j.neurobiolaging.2005.03.008
The effects of APOE and tau gene variability on risk of frontotemporal dementia
L. Bernardi (2006)
10.1136/jnnp.2005.085167
Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury
M. Ariza (2006)
10.1002/ana.20873
Frontotemporal dementia: Clinicopathological correlations
M. Forman (2006)
10.1136/jnnp.2005.063966
The apolipoprotein E ε4 allele selectively increases the risk of frontotemporal lobar degeneration in males
R. Srinivasan (2006)
10.1073/PNAS.0600549103
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.
R. Mahley (2006)
10.1016/j.neurobiolaging.2005.02.005
Dose dependent effect of APOE ɛ4 on behavioral symptoms in frontal lobe dementia
S. Engelborghs (2006)
Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
S. Engelborghs (2006)
10.1111/j.1600-0404.2006.00679.x
Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology
R. Mahley (2006)
10.1111/j.1600-0404.2006.00676.x
ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study
Antti Louko (2006)
10.1016/j.neurobiolaging.2005.03.011
Differences in regional brain atrophy in genetic forms of Alzheimer's disease
G. Gregory (2006)
10.1038/ncpneuro0357
Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
S. Sha (2006)
10.1212/01.wnl.0000259035.98480.ed
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
G. Rabinovici (2007)
10.1093/BRAIN/AWL377
The topography of grey matter involvement in early and late onset Alzheimer's disease.
G. Frisoni (2007)
10.1016/S0010-9452(08)70683-X
Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk
J. Snowden (2007)
10.1016/S1474-4422(07)70221-1
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative
R. Rademakers (2007)
10.1177/1533317507308779
Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
G. Rabinovici (2008)
10.1523/JNEUROSCI.3253-07.2008
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
Qin Xu (2008)
10.1212/01.wnl.0000286941.74372.cc
Apolipoprotein E genotype and memory in the sixth decade of life
M. Schultz (2008)
10.1001/archneurol.2007.38
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia.
W. Seeley (2008)
10.1212/01.wnl.0000304038.37421.cc
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
S. Cosentino (2008)
10.1093/brain/awm320
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
J. Beck (2008)
Clinicopathological case comparison: Familial frontotemporal lobar degeneration-motor neuron disease with phenotypic heterogeneity in two first-degree relatives
K Vossel (2008)
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
S Cosentino (2008)
Clinicopathological case comparison: Familial frontotemporal lobar degeneration-motor neuron disease with phenotypic heterogeneity in two first-degree relatives. Neurology 70(Suppl 1):A275
K Vossel (2008)
10.1212/01.wnl.0000400650.92875.cf
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. Mckhann (2011)



This paper is referenced by
10.1016/j.exger.2020.111216
Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples
Lorenzo Pini (2020)
10.1016/j.bbr.2020.112918
Superior short-term memory in APOE ε2 carriers across the age range
N. Zokaei (2020)
10.1093/braincomms/fcaa219
The human hippocampus and its subfield volumes across age, sex and APOE e4 status
M. Veldsman (2020)
10.1093/brain/awaa457
Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.
I. Hartnell (2021)
10.1080/14737175.2021.1956904
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance
U. Saeed (2021)
10.3233/JAD-201182
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
D. Loeffler (2021)
10.3389/fnagi.2021.736201
Leisure Activities, APOE ε4, and Cognitive Decline: A Longitudinal Cohort Study
Yun Zhang (2021)
10.1007/s40336-021-00440-1
Topographical patterns of whole-brain structural alterations in association with genetic risk, cerebrospinal fluid, positron emission tomography biomarkers of Alzheimer’s disease, and neuropsychological measures
A. Piersson (2021)
10.1016/j.neurobiolaging.2021.02.008
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25
O. Butt (2021)
10.1002/ana.26043
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model
A. Litvinchuk (2021)
10.1101/2021.07.07.451493
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
Sivaprakasam R. Saroja (2021)
10.1016/j.apsb.2021.10.002
Apolipoprotein E and Alzheimer’s disease
(2021)
10.1007/s00401-021-02315-1
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease
S. Kang (2021)
10.3233/JAD-210434
Segmented Linear Mixed Model Analysis Reveals Association of the APOE ɛ4 Allele with Faster Rate of Alzheimer’s Disease Dementia Progression
X. Richard Chen (2021)
10.1242/dmm.045211
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
Julia Gamache (2020)
10.3390/ijms21176336
ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
M. F. Lanfranco (2020)
10.1007/s11682-020-00283-w
APOE ε4 and cognitive reserve effects on the functional network in the Alzheimer’s disease spectrum
Ting Li (2020)
10.3389/fphys.2020.00683
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
D. Liccardo (2020)
10.1186/s13024-020-00382-8
Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice
R. Larramona-Arcas (2020)
10.3389/fnagi.2020.581767
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Natalia A. Salvadores (2020)
10.1038/s41598-020-66114-6
Short-term memory advantage for brief durations in human APOE ε4 carriers
N. Zokaei (2020)
10.7150/thno.48522
Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
Shaozhen Yan (2020)
10.3389/fimmu.2020.00754
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
Courtney M. Kloske (2020)
10.1002/alz.12087
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease
Elizabeth E. Moore (2020)
10.1080/13554794.2020.1787458
Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation
R. Townley (2020)
10.1111/jnc.15170
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease
S. Pedrini (2020)
10.1007/s12035-019-01859-4
Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy
E. Koller (2020)
10.1016/j.bbr.2019.01.043
Impaired conflict monitoring in cognitive decline
Bo-Lin Ho (2019)
10.1111/nan.12529
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
M. Tzioras (2018)
10.2174/1567205016666190823124724
Integrated genomic analysis revealed associated genes for Alzheimer's disease in APOE4 non-carriers.
Shan Jiang (2019)
10.1016/j.neuroscience.2019.01.049
APOE Genotype Specific Effects on the Early Neurodegenerative Sequelae Following Chronic Repeated Mild Traumatic Brain Injury
Phillip Muza (2019)
10.1016/j.neurobiolaging.2018.09.017
Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories
N. Zokaei (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar